(HKEX: 2269)

Wuxi Biologics (Cayman), Inc. is an investment holding company, which engages in the discovery, development and manufacture of biologics services. Its services include testing; clinical drug substance cGMP manufacture; commercial drug substance cGMP manufacture; drug product cGMP fill and finish; antibody drug conjugates; regulatory affairs; and technologies and platforms. The company was founded on May 24, 2010 and is headquartered in Wuxi, China.

40.050 -

-1.650 (-3.96%)
Learn More about DLC
Range 39.300 - 41.450   (5.47%)
Open 41.000
Previous Close 41.700
Buy Price 40.050
Buy Volume 10,942
Sell Price 40.050
Sell Volume 11,106
Volume 37,167.8
Value 1,486,677,665
Remark -
Delayed prices. Updated at 31 May 2023 16:08.
Data powered by
View All Events

Loading Chart...

More Charts Coming Soon...